Skyrizi
NDC 0074-5015 · AbbVie Inc.
Generic namerisankizumab-rzaa
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)RISANKIZUMAB
Strength600 mg/10mL
Pharmacologic classInterleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
Marketing categoryBLA
Packages
0074-5015-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-01) / 10 mL in 1 VIAL, SINGLE-DOSE
0074-5015-02 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-02) / 10 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg Medicare Part B payment limit (ASP + 6%): $14.53
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0074-1050 — risankizumab-rzaa, 0074-2100 — risankizumab-rzaa, 0074-4059 — risankizumab-rzaa, 0074-8300 — risankizumab-rzaa, 0074-8350 — risankizumab-rzaa